Bartlett 2004 Eur J Biochem: Difference between revisions
(Created page with "{{Publication |title=Bartlett K, Eaton S (2004) Mitochondrial beta-oxidation. Eur J Biochem 271:462-9. |info=[https://pubmed.ncbi.nlm.nih.gov/14728673/ PMID:14728673] |authors...") ย |
No edit summary ย |
||
Line 7: | Line 7: | ||
|abstract=Mitochondrial beta-oxidation is a complex pathway involving, in the case of saturated straight chain fatty acids of even carbon number, at least 16 proteins which are organized into two functional subdomains; one associated with the inner face of the inner mitochondrial membrane and the other in the matrix. Overall, the pathway is subject to intramitochondrial control at multiple sites. However, at least in the liver, carnitine palmitoyl transferase I exerts approximately 80% of control over pathway flux under normal conditions. Clearly, when one or more enzyme activities are attenuated because of a mutation, the major site of flux control will change. | |abstract=Mitochondrial beta-oxidation is a complex pathway involving, in the case of saturated straight chain fatty acids of even carbon number, at least 16 proteins which are organized into two functional subdomains; one associated with the inner face of the inner mitochondrial membrane and the other in the matrix. Overall, the pathway is subject to intramitochondrial control at multiple sites. However, at least in the liver, carnitine palmitoyl transferase I exerts approximately 80% of control over pathway flux under normal conditions. Clearly, when one or more enzyme activities are attenuated because of a mutation, the major site of flux control will change. | ||
}} | }} | ||
== Cited by == | |||
{{Template:Cited by Silva 2021 MitoFit Etomoxir}} | |||
{{Labeling | {{Labeling | ||
|additional=MitoFit 2021 Etomoxir | |additional=MitoFit 2021 Etomoxir | ||
}} | }} |
Latest revision as of 11:11, 6 July 2021
Bartlett K, Eaton S (2004) Mitochondrial beta-oxidation. Eur J Biochem 271:462-9. |
Bartlett K, Eaton S (2004) Eur J Biochem
Abstract: Mitochondrial beta-oxidation is a complex pathway involving, in the case of saturated straight chain fatty acids of even carbon number, at least 16 proteins which are organized into two functional subdomains; one associated with the inner face of the inner mitochondrial membrane and the other in the matrix. Overall, the pathway is subject to intramitochondrial control at multiple sites. However, at least in the liver, carnitine palmitoyl transferase I exerts approximately 80% of control over pathway flux under normal conditions. Clearly, when one or more enzyme activities are attenuated because of a mutation, the major site of flux control will change.
Cited by
- Silva et al (2021) Off-target effect of etomoxir on mitochondrial Complex I. MitoFit Preprints 2021. (in preparation)
Labels:
MitoFit 2021 Etomoxir